Oncopharmpod
Gilteritinib
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:17:28
- Mas informaciones
Informações:
Sinopsis
Another week, another FDA-approval for AML. We discuss the latest in #oncopharm approvals: the FLT3-inhibitor gilteritinib. For more background reading, try here: https://doi.org/10.1177%2F1078155218802620
